Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SOLIGENIX, INC.Financial_Report.xls
S-1/A - AMENDMENT NO 1 TO S-1 - SOLIGENIX, INC.fs1oct2014a1_soligenix.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - SOLIGENIX, INC.fs1oct2014a1ex23i_soligenix.htm

 

EXHIBIT 21.1

 

SUBSIDIARIES OF SOLIGENIX, INC.

 

The following represents a list of Soligenix, Inc.’s subsidiaries:

 

Name   Ownership     State of Incorporation  
Enteron Pharmaceuticals, Inc.     100.00 %     Delaware  
Orasomal Technologies Inc.     75.30 %     Delaware  
DOR BioDefense Corp.     100.00 %     Delaware  
Soligenix BioPharma Canada Incorporated     100.00 %     Canada  
Soligenix UK Limited     100.00 %     United Kingdom